StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report released on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
NASDAQ:XXII traded down $0.00 on Thursday, hitting $0.11. The stock had a trading volume of 1,800,466 shares, compared to its average volume of 2,684,957. The stock has a market cap of $5.27 million, a P/E ratio of 0.00 and a beta of 1.45. 22nd Century Group has a 1 year low of $0.09 and a 1 year high of $6.69. The firm’s fifty day simple moving average is $0.20 and its two-hundred day simple moving average is $0.69.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.36) EPS for the quarter. The firm had revenue of $7.95 million during the quarter. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Recommended Stories
- Five stocks we like better than 22nd Century Group
- High Dividend REITs: Are They an Ideal Way to Diversify?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Insider Selling Explained: Can it Inform Your Investing Choices?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- Technology Stocks Explained: Here’s What to Know About Tech
- L3Harris: Positioned for Gains With Trump’s Defense Policies
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.